☰

Amanda E. Boggs, Ph.D. - Publications

Affiliations: 
2014 Molecular Medicine University of Maryland School of Medicine, Baltimore, MD, United States 
Area:
Oncology, Cell Biology, Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Ory E, Bhandary L, Boggs A, Chakrabarti K, Parker J, Losert W, Martin SS. Analysis of microtubule growth dynamics arising from altered actin network structure and contractility in breast tumor cells. Physical Biology. PMID 28092269 DOI: 10.1088/1478-3975/Aa59A2  0.707
2015 Thompson KN, Whipple RA, Yoon JR, Lipsky M, Charpentier MS, Boggs AE, Chakrabarti KR, Bhandary L, Hessler LK, Martin SS, Vitolo MI. The combinatorial activation of the PI3K and Ras/MAPK pathways is sufficient for aggressive tumor formation, while individual pathway activation supports cell persistence. Oncotarget. PMID 26497685 DOI: 10.18632/Oncotarget.6159  0.826
2015 Chakrabarti KR, Whipple RA, Boggs AE, Hessler LK, Bhandary L, Vitolo MI, Thompson K, Martin SS. Pharmacologic regulation of AMPK in breast cancer affects cytoskeletal properties involved with microtentacle formation and re-attachment. Oncotarget. PMID 26431377 DOI: 10.18632/Oncotarget.5345  0.797
2015 Bhandary L, Whipple RA, Vitolo MI, Charpentier MS, Boggs AE, Chakrabarti KR, Thompson KN, Martin SS. ROCK inhibition promotes microtentacles that enhance reattachment of breast cancer cells. Oncotarget. 6: 6251-66. PMID 25749040 DOI: 10.18632/Oncotarget.3360  0.857
2015 Boggs AE, Vitolo MI, Whipple RA, Charpentier MS, Goloubeva OG, Ioffe OB, Tuttle KC, Slovic J, Lu Y, Mills GB, Martin SS. α-Tubulin acetylation elevated in metastatic and basal-like breast cancer cells promotes microtentacle formation, adhesion, and invasive migration. Cancer Research. 75: 203-15. PMID 25503560 DOI: 10.1158/0008-5472.Can-13-3563  0.82
2015 Thompson KN, Whipple RA, Charpentier MS, Boggs AE, Bhandray L, Chakrabarti KR, Martin SS, Vitolo MI. Abstract A32: Cell dormancy and tumorigenicity due to PTEN loss Molecular Cancer Therapeutics. 14. DOI: 10.1158/1538-8514.Pi3K14-A32  0.844
2015 Thompson KN, Whipple RA, Yoon JR, Charpentier MS, Boggs AE, Bhandary L, Chakrabarti KR, Martin SS, Vitolo MI. Abstract 2161: Activation of the MAPK pathway in combination with PTEN loss leads to aggressive primary tumor formation Cancer Research. 75: 2161-2161. DOI: 10.1158/1538-7445.Am2015-2161  0.844
2015 Bhandary L, Whipple RA, Vitolo MI, Charpentier MS, Boggs AE, Chakrabarti KR, Thompson KN, Martin SS. ROCK inhibition promotes microtentacles that enhance reattachment of breast cancer cells Oncotarget. 6: 6251-6266.  0.81
2014 Charpentier MS, Whipple RA, Vitolo MI, Boggs AE, Slovic J, Thompson KN, Bhandary L, Martin SS. Curcumin targets breast cancer stem-like cells with microtentacles that persist in mammospheres and promote reattachment Cancer Research. 74: 1250-1260. PMID 24371229 DOI: 10.1158/0008-5472.Can-13-1778  0.828
2014 Bhandary L, Vitolo MI, Bettes RA, Charpentier MS, Boggs AE, Slovic J, Thompson K, Martin SS. Abstract 3160: ROCK inhibition promotes microtentacle formation and reattachment of breast cancer cells Cancer Research. 74: 3160-3160. DOI: 10.1158/1538-7445.Am2014-3160  0.856
2013 Whipple RA, Vitolo MI, Boggs AE, Charpentier MS, Thompson K, Martin SS. Parthenolide and costunolide reduce microtentacles and tumor cell attachment by selectively targeting detyrosinated tubulin independent from NF-κB inhibition Breast Cancer Research. 15. PMID 24028602 DOI: 10.1186/Bcr3477  0.824
2013 Vitolo MI, Boggs AE, Whipple RA, Yoon JR, Thompson K, Matrone MA, Cho EH, Balzer EM, Martin SS. Loss of PTEN induces microtentacles through PI3K-independent activation of cofilin. Oncogene. 32: 2200-10. PMID 22689060 DOI: 10.1038/Onc.2012.234  0.779
2013 Charpentier MS, Bettes RA, Vitolo MI, Boggs AE, Slovic J, Thompson K, Bhandary L, Yoon J, Martin SS. Abstract 3772: The role of microtentacles in the metastatic potential of breast tumor stem cells. Cancer Research. 73: 3772-3772. DOI: 10.1158/1538-7445.Am2013-3772  0.836
2013 Slovic J, Vitolo MI, Whipple RA, Boggs AE, Charpentier MS, Bhandary L, Thompson K, Martin SS. Abstract 276: Microtentacle stabilization during TGFβ-induced EMT as a new therapeutic target to reduce circulating tumor cell metastasis. Cancer Research. 73: 276-276. DOI: 10.1158/1538-7445.Am2013-276  0.851
2013 Boggs AE, Vitolo MI, Bettes RA, Slovic J, Charpentier MS, Martin SS. Abstract 2627: Acetylation of α-tubulin contributes to microtentacle formation and re-attachment in suspended breast tumor cells. Cancer Research. 73: 2627-2627. DOI: 10.1158/1538-7445.Am2013-2627  0.841
2012 Balzer EM, Tong Z, Paul CD, Hung WC, Stroka KM, Boggs AE, Martin SS, Konstantopoulos K. Physical confinement alters tumor cell adhesion and migration phenotypes. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 26: 4045-56. PMID 22707566 DOI: 10.1096/Fj.12-211441  0.813
2011 Vitolo MI, Boggs AE, Thompson K, Whipple RA, Yoon JR, Slovic J, Charpentier MS, Matrone MA, Martin SS. Abstract 3122: PTEN loss disrupts the actin cortex to promote tubulin microtentacle formation and increased metastatic potential Cancer Research. 71: 3122-3122. DOI: 10.1158/1538-7445.Am2011-3122  0.859
2010 Balzer EM, Whipple RA, Thompson K, Boggs AE, Slovic J, Cho EH, Matrone MA, Yoneda T, Mueller SC, Martin SS. c-Src differentially regulates the functions of microtentacles and invadopodia. Oncogene. 29: 6402-8. PMID 20956943 DOI: 10.1038/Onc.2010.360  0.757
Show low-probability matches.